TITLE
Breast cancer and docetaxel treatment

SUMMARY
Breast cancer core biopsies taken from patients found to be resistant (greater than 25% residual tumor volume) or sensitive (less than 25% residual tumor volume) to docetaxel treatment.

ORGANISM
Homo sapiens

